Manfred Dietel

37.3k total citations · 2 hit papers
528 papers, 26.0k citations indexed

About

Manfred Dietel is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Manfred Dietel has authored 528 papers receiving a total of 26.0k indexed citations (citations by other indexed papers that have themselves been cited), including 233 papers in Oncology, 197 papers in Molecular Biology and 116 papers in Cancer Research. Recurrent topics in Manfred Dietel's work include Cancer Genomics and Diagnostics (69 papers), Lung Cancer Treatments and Mutations (53 papers) and Colorectal Cancer Treatments and Studies (40 papers). Manfred Dietel is often cited by papers focused on Cancer Genomics and Diagnostics (69 papers), Lung Cancer Treatments and Mutations (53 papers) and Colorectal Cancer Treatments and Studies (40 papers). Manfred Dietel collaborates with scholars based in Germany, United States and Switzerland. Manfred Dietel's co-authors include Carsten Denkert, Wilko Weichert, Hermann Lage, Glen Kristiansen, Jan Budczies, Iver Petersen, Aurelia Noske, Silvia Darb‐Esfahani, Silvia Niesporek and Karsten Schlüns and has published in prestigious journals such as Nature, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Manfred Dietel

511 papers receiving 25.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer

2009 1.3k citations Carsten Denkert, Sibylle Loibl et al. profile →
Mucosal flora in inflammatory bowel disease

2002 1.0k citations Manfred Dietel et al. profile →

Peers

Countries citing papers authored by Manfred Dietel

Since Specialization

Citations

This map shows the geographic impact of Manfred Dietel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manfred Dietel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manfred Dietel more than expected).

Fields of papers citing papers by Manfred Dietel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manfred Dietel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manfred Dietel. The network helps show where Manfred Dietel may publish in the future.

Co-authorship network of co-authors of Manfred Dietel

This figure shows the co-authorship network connecting the top 25 collaborators of Manfred Dietel. A scholar is included among the top collaborators of Manfred Dietel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manfred Dietel. Manfred Dietel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Proficiency testing of PIK3CA mutations in HR+/HER2-breast cancer on liquid biopsy and tissue 2022 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Claudia Vollbrecht, Inga Hoffmann, Annika Lehmann, Sabine Merkelbach‐Bruse, Jana Fassunke, Svenja Wagener‐Ryczek, Markus Ball, Lora Dimitrova, Arndt Hartmann, Robert Stöhr, Ramona Erber, Wilko Weichert, Nicole Pfarr, (unknown), Andreas Jung, Wolfgang Dietmaier, Manfred Dietel, David Horst, Michael Hummel	8
2	Tumor mutational burden standardization initiatives: Recommendations for consistent tumor mutational burden assessment in clinical samples to guide immunotherapy treatment decisions 2019 ·Genes Chromosomes and Cancer ·Albrecht Stenzinger, Jeffrey D. Allen, J. Maas, Mark Stewart, Diana M. Merino, (unknown), Manfred Dietel	161
3	HER2 testing in gastric cancer: results of a German expert meeting 2017 ·Journal of Cancer Research and Clinical Oncology ·Florian Lordick, Salah‐Eddin Al‐Batran, Manfred Dietel, Timo Gaiser, Ralf‐Dieter Hofheinz, Thomas Kirchner, Hans Kreipe, Sylvie Lorenzen, Markus Möhler, Alexander Quaas, Christoph Röcken, Josef Rüschoff, Andrea Tannapfel, Peter Thuss‐Patience, Gustavo Baretton	38
4	Accumulated Metabolites of Hydroxybutyric Acid Serve as Diagnostic and Prognostic Biomarkers of Ovarian High-Grade Serous Carcinomas 2016 ·Cancer Research ·Mika Hilvo, Inês de Santiago, Peddinti Gopalacharyulu, Wolfgang Schmitt, Jan Budczies, Marc Kuhberg, Manfred Dietel, Tero Aittokallio, Florian Markowetz, Carsten Denkert, Jalid Sehouli, Christian Frezza, Silvia Darb‐Esfahani, Elena Ioana Braicu	70
5	Prädiktive PD-L1-Immunhistochemie beim nichtkleinzelligen Bronchialkarzinom. Aktueller Stand und Erfahrungen der ersten deutschen Harmonisierungsstudie 2016 ·Der Pathologe ·Andreas H. Scheel, Manfred Dietel, Lukas C. Heukamp, Korinna Jöhrens, T. Kirchner, Simone Reu, Josef Rüschoff, Hans‐Ulrich Schildhaus, Peter Schirmacher, Markus Tiemann, Arne Warth, Wilko Weichert, Rieke Fischer, Julia Wolf, (unknown)	17
6	EGFR Mutation Status and First-Line Treatment in Patients with Stage III/IV Non–Small Cell Lung Cancer in Germany: An Observational Study 2015 ·Cancer Epidemiology Biomarkers & Prevention ·Wolfgang Schuette, Peter Schirmacher, Wilfried Eberhardt, (unknown), J.-Matthias Graf von der Schulenburg, J. Mezger, Christian Schumann, Monika Serke, (unknown), Manfred Dietel, Michael Thomas	29
7	Standardized Ki67 Diagnostics Using Automated Scoring—Clinical Validation in the GeparTrio Breast Cancer Study 2014 ·Clinical Cancer Research ·Frederick Klauschen, Stephan Wienert, Wolfgang Schmitt, Sibylle Loibl, Bernd Gerber, Jens‐Uwe Blohmer, Jens Huober, Thomas Rüdiger, E Erbstösser, Keyur Mehta, Bianca Lederer, Manfred Dietel, Carsten Denkert, Gϋnter von Minckwitz	78
8	Comprehensive analysis of clinico-pathological data reveals heterogeneous relations between atherosclerosis and cancer 2014 ·Journal of Clinical Pathology ·Jan Budczies, Moritz von Winterfeld, Frederick Klauschen, (unknown), Jan‐Marcus Daniel, Arne Warth, Volker Endris, Carsten Denkert, Heriberto Pfeiffer, Wilko Weichert, Manfred Dietel, Daniel Wittschieber, Albrecht Stenzinger	13
9	The Androgen-Regulated Calcium-Activated Nucleotidase 1 (CANT1) Is Commonly Overexpressed in Prostate Cancer and Is Tumor-Biologically Relevant in Vitro 2011 ·American Journal Of Pathology ·Josefine Gerhardt, (unknown), (unknown), Silvia Behnke, (unknown), Florian Fritzsche, Heike Liewen, Frank Stenner, Peter J. Wild, Thomas Hermanns, Michael Müntener, Manfred Dietel, Klaus Jung, Carsten Stephan, Glen Kristiansen	29
10	Genome-wide Gene Expression Profiling of Formalin-fixed Paraffin-Embedded Breast Cancer Core Biopsies Using Microarrays 2011 ·Journal of Histochemistry & Cytochemistry ·Jan Budczies, Wilko Weichert, Aurelia Noske, Berit Müller, Claudia M Weller, Timo Wittenberger, (unknown), Manfred Dietel, Carsten Denkert, Volker Gekeler	27
11	Atypical Protein Kinase C ζ Exhibits a Proapoptotic Function in Ovarian Cancer 2010 ·Molecular Cancer Research ·Irina Nazarenko, Marcel Jenny, Jana Keil, (unknown), (unknown), Jalid Sehouli, Stefan Legewie, (unknown), Wilko Weichert, Silvia Darb‐Esfahani, Manfred Dietel, Reinhold Schäfer, Florian Ueberall, Christine Sers	26
12	METAtarget - Extracting Key Enzymes of Metabolic Regulation from Highthroughput Metabolomics Data using KEGG REACTION Information. 2010 ·Jan Budczies, Carsten Denkert, Berit Müller, Scarlet Brockmöller, Manfred Dietel, Julian L. Griffin, Matej Orešič, Oliver Fiehn	1
13	Hyperactivation of the Insulin-like Growth Factor Receptor I Signaling Pathway Is an Essential Event for Cisplatin Resistance of Ovarian Cancer Cells 2009 ·Cancer Research ·Niels Eckstein, Kati Servan, Barbara Hildebrandt, (unknown), Georg von Jonquières, (unknown), (unknown), Alexandra Hamacher, Matthias U. Kassack, Jan Budczies, Manfred Beier, Manfred Dietel, Brigitte Royer‐Pokora, Carsten Denkert, Hans‐Dieter Royer	134
14	Novel Jet-Injection Technology for Nonviral Intratumoral Gene Transfer in Patients with Melanoma and Breast Cancer 2008 ·Clinical Cancer Research ·Wolfgang Walther, Robert Siegel, Dennis Kobelt, Thomas Knösel, Manfred Dietel, A. Bembenek, Jutta Aumann, Martin Schleef, (unknown), Ulrike Stein, Peter M. Schlag	39
15	Class I Histone Deacetylase Expression Has Independent Prognostic Impact in Human Colorectal Cancer: Specific Role of Class I Histone Deacetylases In vitro and In vivo 2008 ·Clinical Cancer Research ·Wilko Weichert, A.-E. Roske, Silvia Niesporek, Aurelia Noske, Ann‐Christin Buckendahl, Manfred Dietel, Volker Gekeler, Markus Boehm, Thomas Beckers, Carsten Denkert	299
16	Mass Spectrometry–Based Metabolic Profiling Reveals Different Metabolite Patterns in Invasive Ovarian Carcinomas and Ovarian Borderline Tumors 2006 ·Cancer Research ·Carsten Denkert, Jan Budczies, Tobias Kind, Wilko Weichert, (unknown), Jalid Sehouli, Silvia Niesporek, Dominique Könsgen, Manfred Dietel, Oliver Fiehn	304
17	Down-Regulation of Caveolin-1, a Candidate Tumor Suppressor Gene, in Sarcomas 2001 ·American Journal Of Pathology ·Kai Wiechen, Christine Sers, Alexander I. Agoulnik, (unknown), Manfred Dietel, Peter M. Schlag, Ulrike Schneider	148
18	Das UICC-Telepathologie-Konsultationszentrum “Second opinion”über Internet für Pathologen 2001 ·Der Pathologe ·(unknown), Peter Hufnagl, M Bodó, (unknown), Manfred Dietel	1
19	Selection of a high activity ribozyme against cytostatic drug resistance-associated glypican-3 using an in vitro assay containing total tumor RNA 1999 ·Cancer Gene Therapy ·(unknown), Per Sonne Holm, Manfred Dietel, Hermann Lage	6
20	Selection of a high activity c-erbB-2 ribozyme using a fusion gene of c-erbB-2 and the enhanced green fluorescent protein. 1998 ·PubMed ·Kai Wiechen, Christine L. Zimmer, Manfred Dietel	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact